Tower Research Capital (TRC)’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $6.57K | Sell |
|
|||||
|
2024
Q4 | $32.8K | Buy |
|
|||||
|
2024
Q3 | $2.02K | Sell |
|
|||||
|
2024
Q2 | $25.4K | Buy |
|
|||||
|
2024
Q1 | $7.35K | Sell |
|
|||||
|
2023
Q4 | $9.97K | Sell |
|
|||||
|
2023
Q3 | $11.2K | Buy |
|
|||||
|
2023
Q2 | $10.8K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $0 | Sell |
|
|||||
|
2022
Q3 | $5K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $12K | Sell |
|
|||||
|
2021
Q4 | $17K | Buy |
|
|||||
|
2021
Q3 | $19K | Sell |
|
|||||
|
2021
Q2 | $35K | Sell |
|
|||||
|
2021
Q1 | $90K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $9K | Sell |
|
|||||
|
2020
Q2 | $31K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|